ANSYS stock: Ansys set for September 29-30 in silico summit

Ansys is scheduled to participate in the Global In Silico Pharmaceutical Summit on September 29 and 30, 2026. The virtual event will bring together pharmaceutical companies, researchers, regulators and technology providers to discuss computational modeling, simulation, artificial intelligence-enabled analytics and digital twins. Ansys

Focus on pharmaceutical applications

The event agenda covers simulation applications in drug manufacturing, process engineering, drug delivery and clinical trials. The company said presentations involving Ansys, which it identifies as part of Synopsys, will address verification, validation, uncertainty quantification, model credibility and simulation-driven evidence for regulatory submissions. Ansys